Skip to search formSkip to main contentSkip to account menu

tetralol

Known as: 1,2,3,4-tetrahydro-2-naphthol 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Tetralones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Unexpectedly small ortho-oxygen substituent effects on stabilities of benzylic carbocations.
Equilibrium constants are reported for the ionization of benzylic alcohols to carbocations stabilized by cyclic or acyclic o… 
2001
2001
Evidence against an action of mibefradil at N-type voltage-operated calcium channels
Abstract. Mibefradil is a tetralol derivative that inhibits cloned and native T-type voltage-operated calcium channels (VOCCs) at… 
Review
1998
Review
1998
Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension.
1998
1998
Anti-Anginal and Anti-Ischemic Effects of Mibefradil, a New T-Type Calcium Channel Antagonist
Mibefradil is the first of a new class of calcium antagonists (CAs), the tetralol derivatives, that selectively blocks the T-type… 
1998
1998
Single‐ and Multiple‐dose Mibefradil Pharmacokinetics in Normal and Hypertensive Subjects
  • H. Welker
  • The Journal of pharmacy and pharmacology
  • 1998
  • Corpus ID: 26429820
Mibefradil is a single‐enantiomer calcium antagonist belonging to a new class, the tetralol derivatives. The recommended doses… 
Review
1997
Review
1997
Diversity of calcium antagonists.
Review
1997
Review
1997
Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Mibefradil belongs to a new class of calcium antagonists, the tetralol derivatives. It selectively blocks T-type calcium channels… 
Review
1997
Review
1997
Rationale for the use of calcium antagonists in the treatment of silent myocardial ischemia.
1997
1997
Mibefradil: A New Selective T-Channel Calcium Antagonist for Hypertension and Angina Pectoris
Calcium antagonists are an established therapy for patients with hypertension and angina pectoris, but their current usage is… 
1968
1968
Mechanism of aliphatic hydroxylation. Tetralin hydroperoxide as an intermediate in the hydroxylation of tetralin in rat-liver homogenate.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)